Utama › Melanoma › Wilayah Columbia › Washington
Kajian klinikal Melanoma di Washington, DC
17 kajian untuk Melanoma sedang mencari peserta di lokasi dalam dan sekitar Washington (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- National Cancer Institute (NCI), Bethesda · 7 mi jauh
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
Mengambil pesertaFasa 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Evaluation for NCI Surgery Branch Clinical Research Protocols
Mengambil pesertaKajian pemerhatian
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi jauh
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Mengambil pesertaFasa 3
- National Cancer Institute, Bethesda · 7 mi jauh
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Mengambil pesertaFasa 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
Mengambil pesertaFasa 1/2
- Sibley Memorial Hospital, Washington D.C.
Project: Every Child for Younger Patients With Cancer
Mengambil pesertaKajian pemerhatian
- MedStar Georgetown University Hospital, Washington D.C.
- Children's National Medical Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi jauh
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Mengambil pesertaFasa 1/2
- Children's National Medical Center, Washington D.C.
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
Mengambil pesertaFasa 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
Mengambil pesertaFasa 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- National Institutes of Health, Bethesda · 7 mi jauh
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 2
- USA11-0, Bethesda · 7 mi jauh
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Cancer Support Community Research & Training Institute, Washington D.C.
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Mengambil pesertaFasa 2/3
- Georgetown University Medical Center, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi jauh
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi jauh
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Mengambil peserta
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
Kajian Melanoma di bandar lain
- Houston, TX59 kajian
- New York City, NY38 kajian
- Los Angeles, CA34 kajian
- Nashville, TN33 kajian
- Pittsburgh, PA31 kajian
- Boston, MA26 kajian
- Philadelphia, PA23 kajian
- San Francisco, CA22 kajian
- Columbus, OH21 kajian
- Durham, NC21 kajian
- Atlanta, GA21 kajian
- Salt Lake City, UT21 kajian
Kajian lain di Washington
- Kanser (semua jenis)58 kajian
- Kanser Paru-paru Bukan Sel Kecil55 kajian
- Kanser Payudara46 kajian
- Kanser Metastatik43 kajian
- Kanser Paru-paru41 kajian
- Kanser Prostat38 kajian
- Obesiti33 kajian
- Kanser Kolorektal29 kajian
- Penyakit Kardiovaskular28 kajian
- Kanser Pundi Kencing26 kajian
- Leukemia Mieloid Akut24 kajian
- Kanser Ovari23 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.